Impact of mild hypothermia on platelet responsiveness to aspirin and clopidogrel: An in vitro pharmacodynamic investigation

Journal of Cardiovascular Translational Research

Volumn 7, Issue 1, 2014, Pages 39-46

  Ferreiro, José Luis ^a   Sánchez Salado, José Carlos ^a   Gracida, Montserrat ^a   Marcano, Ana Lucrecia ^a   Roura, Gerard ^a   Ariza, Albert ^a   Gómez Lara, Josep ^a   Lorente, Victoria ^a   Romaguera, Rafael ^a   Homs, Sílvia ^a   Sánchez Elvira, Guillermo ^a   Teruel, Luis ^a   Rivera, Kristian ^a   Sosa, Silvia Gabriela ^a   Gómez Hospital, Joan Antoni ^a   Angiolillo, Dominick J ^b   Cequier, Ángel ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Antiplatelet therapy; ST elevation myocardial infarction; Therapeutic hypothermia

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; IN VITRO STUDY; INDUCED HYPOTHERMIA; LOADING DRUG DOSE; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PHARMACODYNAMICS; PLATELET REACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOCYTE AGGREGATION INHIBITION;

AGED; ASPIRIN; BLOOD PLATELETS; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOTHERMIA, INDUCED; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; RECEPTORS, PURINERGIC P2Y12; RISK FACTORS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84896718990     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-013-9533-5     Document Type: Article

References (48)

1. Peberdy, M. A., Callaway, C. W., Neumar, R. W., et al. (2010). Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation, 122(18 Suppl 3), S768-S786. doi: 10.1161/CIRCULATIONAHA.110.971002.
2. Hypothermia after Cardiac Arrest Study Group. (2002). Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. New England Journal of Medicine, 346, 549-556. doi: 10.1056/NEJMoa012689.
3. Bernard, S. A., Gray, T. W., Buist, M. D., et al. (2002). Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. New England Journal of Medicine, 346, 557-563.
4. Spaulding, C. M., Joly, L. M., Rosenberg, A., et al. (1997). Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. New England Journal of Medicine, 336, 1629-1633. doi: 10.1056/NEJM199706053362302.
5. Anyfantakis, Z. A., Baron, G., Aubry, P., et al. (2009). Acute coronary angiographic findings in survivors of out-of-hospital cardiac arrest. American Heart Journal, 157, 312-318. doi: 10.1016/j.ahj.2008.09.016.
6. Dumas, F., White, L., Stubbs, B. A., Cariou, A., & Rea, T. D. (2012). Long-term prognosis following resuscitation from out of hospital cardiac arrest: role of percutaneous coronary intervention and therapeutic hypothermia. Journal of the American College of Cardiology, 60, 21-27. doi: 10.1016/j.jacc.2012.03.036.
7. Ibrahim, K. (2011). Increased rate of stent thrombosis due to clopidogrel resistance in patients in therapeutic hypothermia after sudden cardiac death. European Heart Journal, 32(Suppl), 252 [abstract].
8. Penela, D., Magaldi, M., Fontanals, J., et al. (2013). Hypothermia in acute coronary syndrome: brain salvage versus stent thrombosis? Journal of the American College of Cardiology, 61, 686-687. doi: 10.1016/j.jacc.2012.10.029.
9. O'Gara, P. T., Kushner, F. G., Ascheim, D. D., et al. (2013). 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 61, e78-e140. doi: 10.1016/j.jacc.2012.11.019.
10. Ferreiro, J. L., & Angiolillo, D. J. (2012). New directions in antiplatelet therapy. Circulation Cardiovascular Interventions, 5, 433-445. doi: 10.1161/CIRCINTERVENTIONS.111.966176.
11. Angiolillo, D. J., & Ferreiro, J. L. (2010). Platelet adenosine diphosphate P2Y12 receptor antagonism: benefits and limitations of current treatment strategies and future directions. Revista Española de Cardiología, 63, 60-76. doi: 10.1016/S1885-5857(10)70010-4.
12. Xavier, R. G., White, A. E., Fox, S. C., Wilcox, R. G., & Heptinstall, S. (2007). Enhanced platelet aggregation and activation under conditions of hypothermia. Thrombosis and Haemostasis, 98, 1266-1275. doi: 10.1160/TH07-03-0189.
13. Scharbert, G., Kalb, M. L., Essmeister, R., & Kozek-Langenecker, S. A. (2010). Mild and moderate hypothermia increases platelet aggregation induced by various agonists: a whole blood in vitro study. Platelets, 21, 44-48. doi: 10.3109/09537100903420269.
14. Högberg, C., Erlinge, D., & Braun, O. O. (2009). Mild hypothermia does not attenuate platelet aggregation and may even increase ADP-stimulated platelet aggregation after clopidogrel treatment. Thrombosis Journal, 7, 2. doi: 10.1186/1477-9560-7-2.
15. Bjelland, T. W., Hjertner, Ø., Klepstad, P., Kaisen, K., Dale, O., & Haugen, B. O. (2011). Antiplatelet effect of clopidogrel is reduced in patients treated with therapeutic hypothermia after cardiac arrest. Resuscitation, 81, 1627-1631. doi: 10.1016/j.resuscitation.2010.07.002.
16. Sibbing, D., Braun, S., Jawansky, S., et al. (2008). Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thrombosis and Haemostasis, 99, 121-126. doi: 10.1160/TH07-07-0478.
17. Bonello, L., Tantry, U. S., Marcucci, R., et al. (2010). Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. Journal of the American College of Cardiology, 56, 919-933. doi: 10.1016/j.jacc.2010.04.047.
18. Malinin, A., Pokov, A., Spergling, M., et al. (2007). Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study. Thrombosis Research, 119, 277-284. doi: 10.1016/j.thrombres.2006.01.019.
19. Fox, S. C., Behan, M. W., & Heptinstall, S. (2004). Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1. Cell Calcium, 35, 39-46. doi: 10.1016/s0146-4060(03)00170-2.
20. Stone, G. W., Witzenbichler, B., Weisz, G., et al. (2013). Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study. Lancet, 382, 614-623. doi: 10.1016/S0140-6736(13)61170-8.
21. Anderson, J. L., Adams, C. D., Antman, E. M., et al. (2013). 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 61, e179-e347. doi: 10.1016/j.jacc.2013.01.014.
22. Laver, S., Farrow, C., Turner, D., & Nolan, J. (2004). Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Medicine, 30, 2126-2128. doi: 10.1007/s00134-004-2425-z.
23. Nielsen, N., Wetterslev, J., Cronberg, T., et al. (2013). Targeted temperature management at 33 C versus 36 C after cardiac arrest. New England Journal of Medicine, 369, 2197-2206. doi: 10.1056/NEJMoa1310519.
24. Soffer, D., Moussa, I., Harjai, K. J., et al. (2003). Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: do we need more aggressive dosing regimens in unstable angina? Catheterization and Cardiovascular Interventions, 59, 21-25. doi: 10.1002/ccd.10494.
25. Sibbing, D., von Beckerath, O., Schömig, A., Kastrati, A., & von Beckerath, N. (2007). Platelet function in clopidogrel-treated patients with acute coronary syndrome. Blood Coagulation and Fibrinolysis, 18, 335-339. doi: 10.1097/MBC.0b013e3280d21aed.
26. Bonello, L., Berbis, J., Laine, M., et al. (2012). Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction. Thrombosis and Haemostasis, 108, 101-106. doi: 10.1160/TH12-02-0125.
27. Montalescot, G., Sideris, G., Meuleman, C., et al. (2006). A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial. Journal of the American College of Cardiology, 48, 931-938. doi: 10.1016/j.jacc.2006.04.090.
28. von Beckerath, N., Taubert, D., Pogatsa-Murray, G., Schömig, E., Kastrati, A., & Schömig, A. (2005). Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. Circulation, 112, 2946-2950. doi: 10.1161/CIRCULATIONAHA.105.559088.
29. Hochholzer, W., Trenk, D., Frundi, D., et al. (2005). Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention. Circulation, 111, 2560-2564. doi: 10.1161/01.CIR.0000160869.75810.98.
30. Heestermans, A. A., van Werkum, J. W., Taubert, D., et al. (2008). Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction. Thrombosis Research, 122, 776-781. doi: 10.1016/j.thromres.2008.01.021.
31. Nührenberg, T. G., Trenk, D., Leggewie, S., et al. (2012). Clopidogrel pretreatment of patients with ST-elevation myocardial infarction does not affect platelet reactivity after subsequent prasugrel-loading: platelet reactivity in an observational study. Platelets, 24, 549-553. doi: 10.3109/09537104.2012.736045.
32. Ferreiro, J. L., Homs, S., Berdejo, J., et al. (2013). Clopidogrel pretreatment in primary percutaneous coronary intervention: prevalence of high on-treatment platelet reactivity and impact on preprocedural patency of the infarct-related artery. Thrombosis and Haemostasis, 110, 110-117. doi: 10.1160/TH13-01-0057.
33. Rosillo, S. O., Lopez-de-Sa, E., Iniesta, A. M., et al. (2013). Is therapeutic hypothermia a risk factor for stent thrombosis? Journal of the American College of Cardiology. doi: 10.1016/j.jacc.2013.09.028.
34. Polderman, K. H. (2009). Mechanisms of action, physiological effects, and complications of hypothermia. Critical Care Medicine, 37(7 Suppl), S186-S202. doi: 10.1097/CCM.0b013e3181aa5241.
35. Arpino, P. A., & Greer, D. M. (2008). Practical pharmacologic aspects of therapeutic hypothermia after cardiac arrest. Pharmacotherapy, 28, 102-111. doi: 10.1592/phco.28.1.102.
36. Frelinger, A. L., 3rd, Furman, M. I., Barnard, M. R., Krueger, L. A., Dae, M. W., & Michelson, A. D. (2003). Combined effects of mild hypothermia and glycoprotein IIb/IIIa antagonists on platelet-platelet and leukocyte-platelet aggregation. American Journal of Cardiology, 92, 1099-1101. doi: 10.1016/j.amjcard.2003.06.007.
37. Scharbert, G., Kalb, M., Marschalek, C., & Kozek-Langenecker, S. A. (2006). The effects of test temperature and storage temperature on platelet aggregation: a whole blood in vitro study. Anesthesia and Analgesia, 102, 1280-1284. doi: 10.1213/01.ane.0000199399.04496.6d.
38. Faraday, N., & Rosenfeld, B. A. (1998). In vitro hypothermia enhances platelet GPIIb-IIIa activation and P-selectin expression. Anesthesiology, 88, 1579-1585. doi: 10.1097/00000542-199806000-00022.
39. Straub, A., Krajewski, S., Hohmann, J. D., et al. (2011). Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 1607-1616. doi: 10.1161/ATVBAHA.111. 226373.
40. Tablin, F., Oliver, A. E., Walker, N. J., Crowe, L. M., & Crowe, J. H. (1996). Membrane phase transition of intact human platelets: correlation with cold-induced activation. Journal of Cellular Physiology, 168, 305-313. doi: 10.1002/(SICI)1097-4652(199608)168:2<305::AID-JCP9>3.0.CO;2-T.
41. Berlin, E., Shapiro, S. G., & Friedland, M. (1984). Platelet membrane fluidity and aggregation of rabbit platelets. Atherosclerosis, 51, 223-239. doi: 10.1016/0021-9150(84)90170-9.
42. Wiviott, S. D., Braunwald, E., McCabe, C. H., et al. (2007). Prasugrel versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine, 357, 2001-2015. doi: 10.1056/NEJMoa0706482.
43. Wallentin, L., Becker, R. C., Budaj, A., et al. (2009). Ticagrelor versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine, 361, 1045-1057. doi: 10.1056/NEJMoa0904327.
44. Parodi, G., Valenti, R., Bellandi, B., et al. (2013). Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study. Journal of the American College of Cardiology, 61, 1601-1606. doi: 10.1016/j.jacc.2013.01.024.
45. Alexopoulos, D., Xanthopoulou, I., Gkizas, V., et al. (2012). Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction. Circulation Cardiovascular Interventions, 5, 797-804. doi: 10.1161/CIRCINTERVENTIONS.112.972323.
46. Ueno, M., Ferreiro, J. L., & Angiolillo, D. J. (2010). Update on the clinical development of cangrelor. Expert Review of Cardiovascular Therapy, 8, 1069-1077. doi: 10.1586/erc.10.90.
47. Angiolillo, D. J., Schneider, D. J., Bhatt, D. L., et al. (2012). Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials. Journal of Thrombosis and Thrombolysis, 34, 44-55. doi: 10.1007/s11239-012-0737-3.
48. Krajewski, S., Kurz, J., Neumann, B., et al. (2012). Short-acting P2Y12 blockade to reduce platelet dysfunction and coagulopathy during experimental extracorporeal circulation and hypothermia. British Journal of Anaesthesia, 108, 912-921. doi: 10.1093/bja/aer518.